Q3 Earnings Alert! Plan early for this week’s stock reports with all key data in 1 placeSee list

Advanz Pharma Corp (CXRXF)

OTC Markets
Currency in USD
Disclaimer
4.60
-0.41(-8.18%)
Closed

CXRXF Cash Flow Statement

Advanced Cash Flow Statement
Collapse All
Period Ending:
2013
31/12
2014
31/12
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
Cash from Operations
aa.aaaa.aaaa.aaaa.aaaa.aa141.62188.18166.21
Cash from Operations Growth
Net Income
Depreciation & Amortisation, Total
Amortisation of Deferred Charges, Total
Other Non-Cash Items, Total
Change in Net Operating Assets
Cash from Investing
aa.aaaa.aaaa.aaaa.aaaa.aa-1.97-34.25-159
Cash from Investing Growth
Capital Expenditure
Sale of Property, Plant, and Equipment
Cash Acquisitions
Divestitures
Other Investing Activities
Cash from Financing
aa.aaaa.aaaa.aaaa.aaaa.aa-224.68-129.93-114.64
Cash from Financing Growth
Total Debt Issued
Short Term Debt Issued, Total
Long-Term Debt Issued, Total
Total Debt Repaid
Short Term Debt Repaid, Total
Long-Term Debt Repaid, Total
Issuance of Common Stock
Repurchase of Common Stock
Issuance of Preferred Stock
Repurchase of Preferred Stock
Common & Preferred Stock Dividends Paid
Special Dividend Paid
Other Financing Activities
Foreign Exchange Rate Adjustments
Miscellaneous Cash Flow Adjustments
Net Change in Cash
aa.aaaa.aaaa.aaaa.aaaa.aa-102.5936.7-100.95
Beginning Cash Balance
Ending Cash Balance
Levered Free Cash Flow
Levered Free Cash Flow Growth
Free Cash Flow Yield
aa.aaaa.aaaa.aaaa.aaaa.aa327.03224.44261.14
aa.aaaa.aaaa.aaaa.aaaa.aa224.44261.14160.19
aa.aaaa.aaaa.aaaa.aaaa.aa-0.63132.79-6.92
aa.aaaa.aaaa.aaaa.aaaa.aa-100.43%+21,110.94%-105.21%
aa.aaaa.aaaa.aaaa.aaaa.aa46.10%107.00%34.79%
* In Millions of USD (except for per share items)